Madrigal Pharmaceuticals

YTD

ALL

Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDGL

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.

CEO

William J. Sibold

CEOWilliam J. Sibold

Employees

528

Employees528

Headquarters

West Conshohocken, Pennsylvania

HeadquartersWest Conshohocken, Pennsylvania

Founded

2000

Founded2000

Employees

528

Employees528

MDGL Key Statistics

Market cap

10.49B

Market cap10.49B

Price-Earnings ratio

-36.42

Price-Earnings ratio-36.42

Dividend yield

—

Dividend yield—

Average volume

372.19K

Average volume372.19K

High today

$482.99

High today$482.99

Low today

$458.07

Low today$458.07

Open price

$474.31

Open price$474.31

Volume

163.78K

Volume163.78K

52 Week high

$615.00

52 Week high$615.00

52 Week low

$265.00

52 Week low$265.00

Stock Snapshot

The current Madrigal Pharmaceuticals(MDGL) stock price is $461.68, with a market capitalization of 10.49B. The stock trades at a price-to-earnings (P/E) ratio of -36.42.

On 2026-02-13, Madrigal Pharmaceuticals(MDGL) stock moved within a range of $458.07 to $482.99. With shares now at $461.68, the stock is trading +0.8% above its intraday low and -4.4% below the session's peak.

Trading activity shows a volume of 163.78K, compared to an average daily volume of 372.19K.

The stock's 52-week range extends from a low of $265.00 to a high of $615.00.

MDGL News

TipRanks 2d

Madrigal Pharmaceuticals announces exclusive license pact with Suzho Ribo

Madrigal Pharmaceuticals (MDGL) announced an exclusive global license agreement with Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals for si...

Simply Wall St 6d

A Look At Madrigal Pharmaceuticals Valuation After Recent Share Price Move

Advertisement Why Madrigal Pharmaceuticals Is On Investors’ Radar Madrigal Pharmaceuticals (MDGL) has drawn attention after a recent move in its share price,...

Analyst ratings

83%

of 18 ratings

Buy

83.3%

Hold

11.1%

Sell

5.6%

People also own

Based on the portfolios of people who own MDGL. This list is generated using Robinhood data, and it’s not a recommendation.

Eli Lilly

Viking Therapeutics

Novo Nordisk

Taiwan Semiconductor Manu…

Broadcom

AMD

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.